Pharmafile Logo
Pharmafocus logo
Advanced Search

Astellas

Showing 15 posts of 103 posts found.

Amgen image

Amgen moves into Japanese market with Astellas deal

May 29, 2013
Sales and Marketing Amgen, Astellas, Vectibix, Zhejiang

Amgen and Astellas have announced a new collaboration that will see them launch five new medicines in Japan from 2016, …

News

Orphan drug for Astellas

May 29, 2013
Sales and Marketing Astellas, Isavuconazole, Orphan

The FDA has granted orphan designation to one of Astellas’ Phase III drugs designed to treat potentially life-threatening fungal infections …

News

Pulse mistake costs Astellas

March 15, 2013
Medical Communications, Sales and Marketing ABPI, Astellas, PMCPA, pulse

A mistake by medical journal Pulse has landed Astellas Pharma in hot water with the PMCPA, enforcers of the ABPI …

News

Astellas appoints VP of Scientific and Medical Affairs

November 9, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Jeffrey Bloss

Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …

Appointment
pat_mccauley_214x164

Astellas announces compliance officer for the Americas

October 26, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, McCauley

Astellas recently named J. Patrick McCauley Jr, a longtime pharmaceutical industry veteran and Astellas employee, to the post of Regional …

Appointment

Astellas appoints Jo Underhill as Sales and Marketing director

September 14, 2012
Business Services, Research and Development, Sales and Marketing Astellas, Jo Underhill

Astellas Pharma has appointed Jo Underhill as Sales and Marketing director, Urology/Dermatology, completing its UK management team. Reporting directly to …

Appointment
dr_susan_wood

Astellas Pharma Europe appoints new senior director

August 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Susan Wood

Astellas Pharma Europe has appointed Dr Susan Wood as senior director, Market Access. Formerly senior brand director of APEL’s Pain Management …

Appointment

FDA approves Astellas’ leaky bladder drug

July 3, 2012
Sales and Marketing Astellas, FDA, Myrbetriq, bladder, urology

The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq.   Myrbetriq (mirabegron), the first drug in its class, works …

News

Astellas submits new prostate cancer drug to EMA

June 28, 2012
Research and Development, Sales and Marketing Astellas, EMA, Medivation, NICE, Zytiga, enzalutamide

Astellas has submitted its investigational prostate cancer drug enzalutamide to the European Medicines Agency. Enzalutamide is a once-daily pill that works …

News

Prostate cancer drug extends life after chemotherapy

March 29, 2012
Research and Development, Sales and Marketing Astellas, Medivation, Zytiga, prostate cancer

Prostate cancer treatment MDV3100 has been shown to extend life by nearly five months in men with advanced disease who …

News

Astellas adds two senior executives at US site

December 5, 2011
Business Services, Manufacturing and Production, Sales and Marketing Astellas

Astellas’ US subsidiary Agensys has appointed Frank Hudson as vice president of finance, and Wolfgang Noe as vice president of …

Appointment

Astellas abandons oral anticoagulant darexaban

September 30, 2011
Research and Development Astellas, Eliquis, Xarelto, darexaban

Astellas Pharma has abandoned the development of its oral direct factor Xa inhibitor darexaban. The Japanese firm blamed both the …

News
ken_jones

Ken Jones appointed head of Astellas Europe

April 13, 2011
Astellas, Ken Jones

Astellas has appointed Ken Jones as its president and chief executive in Europe. Jones had been the chief operating officer …

Appointment
Japanese rescue workers

Japan’s pharma industry pledges to maintain medicines supply

March 17, 2011
Sales and Marketing Astellas, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Japan, earthquake

Pharmaceutical firms in Japan have escaped the very worst of the devastation caused by the earthquake and tsunami, and have …

News

Astellas to commercialise new kidney cancer drug in Europe

February 21, 2011
Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib

Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024